Results 11 to 20 of about 334,289 (309)

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

Therapeutics and Clinical Risk Management, 2008
Daanish Hoda1, George R Simon1, Christopher R Garrett1,21Division of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 2Current affiliation: Department of Gastrointestinal Oncology, The University of Texas ...
Daanish Hoda, George R Simon, Christopher R Garrett   +2 more
doaj   +1 more source

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy

Biologics: Targets & Therapy, 2009
Bryan A Faller, Barbara BurtnessDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAAbstract: Pancreatic adenocarcinoma is a common malignancy that remains refractory to available therapies.
Bryan A Faller, Barbara Burtness
doaj   +2 more sources

Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations

International Journal of Women's Health, 2014
Nathan WD Lamond, Tallal YounisDepartment of Medicine, Dalhousie University at the Queen Elizabeth II Health Sciences Centre, Halifax, NS, CanadaAbstract: In the absence of specific therapy, the 15%–20% of breast cancers demonstrating human ...
Lamond NW, Younis T
doaj   +1 more source

Cluster analysis of deterioration sites after first-line epidermal growth factor receptor-tyrosine kinase inhibitor in epidermal growth factor receptor mutated non-small cell lung cancer

Contemporary Oncology, 2022
INTRODUCTION: For epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC), no studies have treated the site of recurrence after first-line tyrosine kinase inhibitor (TKI) treatment as a “metastasis pattern”.
Shinichiro Okauchi, Kunihiko Miyazaki, Hiroaki Satoh   +2 more
doaj   +2 more sources

Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide

International Journal of Nanomedicine, 2014
Khaled Messaoudi,1 Patrick Saulnier,1 Kim Boesen,1 Jean-Pierre Benoit,1,2 Frederic Lagarce1,21L'Université Nantes Angers Le Mans, INSERM U1066, Micro et nanomédecines biomimétiques, Angers, France; 2Pharmacy Department, Angers ...
Messaoudi K, Saulnier P, Boesen K, Benoit JP, Lagarce F   +4 more
doaj   +1 more source

The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha [PDF]

, 2002
Heparin-binding epidermal growth factor (HB-EGF), a member of the epidermal growth factor (EGF) family, is implicated in a variety of biological processes, including reproduction.
Mardon, Helen J., Yoo, Hyung-J, Katya Chobotova, Barlow, David, Helen J. Mardon, Carver, J, Chobotova, K, Muchmore, ME, William J. Gullick, Muchmore, Mary-Elizabeth, Chobotova, Katya, Janet Carver, Yoo, HJ, Hyung-J Yoo, David H. Barlow, Manek, Sanjiv, Sanjiv Manek, Manek, S, Barlow, DH, Mary-Elizabeth Muchmore, Gullick, WJ, Gullick, William J., Carver, Janet, Mardon, HJ   +23 more
core   +1 more source

A novel small peptide as an epidermal growth factor receptor targeting ligand for nanodelivery in vitro

International Journal of Nanomedicine, 2013
Cui-yan Han,1,2 Li-ling Yue,2 Ling-yu Tai,1 Li Zhou,2 Xue-yan Li,2 Gui-hua Xing,2 Xing-gang Yang,1 Ming-shuang Sun,1 Wei-san Pan1 1School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, People’s Republic of China; 2Qiqihar Medical ...
Han CY, Yue LL, Tai LY, Zhou L, Li XY, Xing GH, Yang XG, Sun MS, Pan WS   +8 more
doaj   +1 more source

Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer [PDF]

, 2001
The epidermal growth factor (EGF) family of ligands and receptors interact to influence cell division, differentiation and motility. Much evidence supports their importance in causing and sustaining cell transformation in model systems and in human ...
Gullick, William J.
core   +1 more source

Epidermal growth factor receptor in glioblastoma

Oncology Letters, 2017
Mutations in the epidermal growth factor receptor (EGFR) are commonly occurring in glioblastoma. Enhanced activation of EGFR can occur through a variety of different mechanisms, both ligand-dependent and ligand-independent. Numerous evidence has suggested that EGFR is overexpressed in most of primary glioblastomas and some of the secondary ...
Xu, Hongsheng, Zong, Hailiang, Ma, Chong, Ming, Xing, Shang, Ming, Li, Kai, He, Xiaoguang, Du, Hai, Cao, Lei   +8 more
openaire   +3 more sources

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling [PDF]

, 2004
Background: We have shown previously that whereas overexpression of human epidermal growth factor receptor (HER) 1, HER2 and HER3 is associated with poor prognosis in breast cancer, HER4 is associated with a good prognosis.
Reeves, J.R., Cooke, T.G., Caroline J Witton, Peter D Stanton, Timothy G Cooke, John MS Bartlett, Witton, C.J., Tovey, S.M., Bartlett, J.M.S., Sian M Tovey, Jonathan R Reeves, Stanton, P.D.   +11 more
core   +1 more source